Indian Patent Office rejects Saxagliptin compulsory license application

被引：0

作者：

Agarwal, Devika ^{[1
]}

Agarwal, Radhika ^{[1
]}

机构：

[1] IIT Madras, MHRD IPR Chair, Madras, Tamil Nadu, India

来源：

JOURNAL OF INTELLECTUAL PROPERTY LAW & PRACTICE | 2016年 / 11卷 / 08期

关键词：

D O I：

10.1093/jiplp/jpw064

中图分类号：

D9 [法律]; DF [法律];

学科分类号：

0301 ;

摘要：

The Controller of Patents (Patent Office, Mumbai) rejected Lee Pharma's compulsory licence application for AstraZeneca's Saxagliptin for failure to provide evidence leading to the application of any of the grounds under section 84 of the Patents Act 1970.

引用

页码：565 / 566

页数：2